TruNorth Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-242
Closed -$20.3K 284
2025
Q3
$20.3K Buy
242
+70
+41% +$5.77K ﹤0.01% 287
2025
Q2
$13.6K Sell
172
-72
-30% -$5.72K ﹤0.01% 270
2025
Q1
$21.9K Sell
244
-72
-23% -$6.72K 0.01% 296
2024
Q4
$31.4K Buy
316
+144
+84% +$14.8K 0.01% 195
2024
Q3
$19.5K Buy
172
+32
+23% +$3.8K 0.01% 235
2024
Q2
$17.3K Buy
140
+84
+150% +$10.8K 0.01% 211
2024
Q1
$7.39K Buy
+56
New +$6.9K ﹤0.01% 192

Other funds holding MRK

TruNorth Capital Management's MRK Position: Q4 2025 in Review

TruNorth Capital Management sold out of Merck (MRK) in Q4 2025, closing a stake of 242 shares — an estimated $20.3K sold.

TruNorth Capital Management first reported a position in MRK in Q1 2024 and held it in 7 quarters. The position peaked at $31.4K in Q4 2024. 3,653 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • TruNorth Capital Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • TruNorth Capital Management sold 242 Merck shares in Q4 2025, an estimated $20.3K.
  • TruNorth Capital Management first reported a position in Merck in Q1 2024 and held it in 7 quarters.
  • TruNorth Capital Management's Merck position peaked at $31.4K in Q4 2024.
  • 3,653 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on TruNorth Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.